• Evolus to Participate in the 7th Annual Truist Securities Life Sciences Summit

    المصدر: Nasdaq GlobeNewswire / 29 أبريل 2021 16:05:01   America/New_York

    NEWPORT BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in the 7th Annual Truist Securities Life Sciences Summit.

    Event:7th Annual Truist Securities Life Sciences Summit
    Format:Fireside Chat & 1x1 Meetings
    Date:Wednesday, May 5, 2021
    Time:3:30pm – 4:10pm ET
    Location:Evolus Live Fireside Chat

    An audio webcast of Evolus’ fireside chat will be available on the investor relations section of Evolus’ website at investors.evolus.com. Replay of the webcast will be available for 90 days after the date of the presentation.

    About Evolus, Inc.

    Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: www.evolus.com.

    Jeuveau® is a registered trademark of Evolus, Inc.

    Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd.

    Investor Contact
    The Ruth Group
    Christine Petraglia
    Senior Vice President
    Tel: 917-633-8980
    Email: cpetraglia@theruthgroup.com


    Primary Logo

شارك على،